Cardiovascular health and menopause in aging women with polycystic ovary syndrome

Helvaci N., Yildiz B. O.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, cilt.15, sa.1, ss.29-39, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 15 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/17446651.2020.1719067
  • Dergi Adı: EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.29-39
  • Anahtar Kelimeler: Polycystic ovary syndrome, hyperandrogenism, menopause, atherosclerosis, cardiovascular disease, CORONARY-ARTERY-DISEASE, ENDOGENOUS SEX-HORMONES, INTIMA-MEDIA THICKNESS, ALL-CAUSE MORTALITY, POSTMENOPAUSAL WOMEN, FOLLOW-UP, RISK-FACTORS, TESTOSTERONE LEVELS, HEART-DISEASE, NATIONWIDE POPULATION
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder with heterogeneous clinical manifestations. Current evidence suggests that women with PCOS exhibit an unfavorable metabolic profile which may pose them at increased risk for cardiovascular events later in life. Areas covered: Herein, we present a review of the existing literature relating to PCOS and long-term cardiovascular (CV) health risks in women after menopause. We performed an electronic-based search with the use of PubMed from 1990 to August 2019 and systematically reviewed studies assessing CV events in women with PCOS. We aimed to outline the gaps in the current evidence and suggest areas for future research. Expert opinion: Although there is a clear association between PCOS and cardiometabolic dysfunction, data on actual cardiovascular disease (CVD) events are conflicting. Additional large, prospective cohort studies of well-phenotyped women with PCOS and long-term follow-up into the late menopause are needed to elucidate the true CVD risk in this population.